Printer Friendly

SCHERER ANNOUNCES LAUNCH OF ANOTHER PRODUCT UTILIZING ITS ZYDIS TECHNOLOGY

 TROY, Mich., Nov. 9 /PRNewswire/ -- R.P. Scherer Corporation (NYSE: SHR) announced today that Janssen Pharmaceutica has launched Imodium Lingual in Germany. Imodium Lingual is a loperamide tablet utilizing R.P. Scherer's Zydis(R) fast dissolving dosage form technology. Loperamide is a widely used product for the treatment of diarrhea and has been available in Germany since 1976.
 The patented Zydis(R) technology enables pharmaceutical products to be made in a form which dissolves instantaneously on the tongue and which does not require water to aid swallowing. It is particularly suitable for patients who have problems swallowing traditional tablets and hardshell capsules. In surveys of patient preference, over 70 percent have preferred the Zydis(R) formulation to conventional tablets.
 A spokesman for Scherer stated, "This is the second new Zydis(R) product to be launched within the last few months. We have an extensive portfolio of products in development and expect many of the top international pharmaceutical companies to have at least one product marketed in this dosage form within the next five years".
 R.P. Scherer Corporation, an international developer and manufacturer of drug delivery systems, is the world's largest producer of soft gelatin capsules ("softgels"). The company is currently developing and commercializing advanced drug delivery systems, including SCHERERSOL(TM), ZYDIS(R) and PULSINCAP(R) technologies. The company's proprietary drug delivery systems improve the efficacy of drugs by regulating the dosage, rate of absorption and place of release. The company operates a global network of 18 facilities in 11 countries.
 Imodium Lingual is a trademark of Janssen Pharmaceutica.
 Scherersol, Zydis and Pulsincap are trademarks of R.P. Scherer Corporation.
 -0- 11/9/93
 /CONTACT: Nicole Williams, Executive VP & CFO of R.P. Scherer, 313-649-0900/
 (SHR)


CO: R.P. Scherer Corporation ST: Michigan IN: MTC SU: PDT

ML -- DE017 -- 2271 11/09/93 13:10 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 9, 1993
Words:306
Previous Article:AJAY COMPLETES THIRD QUARTER
Next Article:NOBILITY HOMES, INC. ANNOUNCES OUTSTANDING FOURTH QUARTER AND YEAR END SALES AND PROPOSED ACQUISITION
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters